Handelsbanken Fonder Ab Argenx Se Transaction History

Handelsbanken Fonder Ab

$25.3 Billion
Q3 2024

A detailed history of Handelsbanken Fonder Ab transactions in Argenx Se stock. As of the latest transaction made, Handelsbanken Fonder Ab holds 27,642 shares of ARGX stock, worth $15.6 Million. This represents 0.06% of its overall portfolio holdings.

Number of Shares

27,642

Previous 27,418 0.82%

Holding current value

$15.6 Million

Previous $11.8 Million 27.08%

% of portfolio

0.06%

Previous 0.05%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 04, 2024	BUY	$434.22 - $551.9 $97,265 - $123,625	224 Added 0.82%	27,642 $15 Million
Q2 2024 Aug 05, 2024	BUY	$356.01 - $451.55 $283,739 - $359,885	797 Added 2.99%	27,418 $11.8 Million
Q1 2024 May 13, 2024	BUY	$356.95 - $413.29 $274,137 - $317,406	768 Added 2.97%	26,621 $10.5 Million
Q4 2023 Feb 01, 2024	SELL	$338.91 - $506.01 $546,661 - $816,194	-1,613 Reduced 5.87%	25,853 $9.84 Million
Q3 2023 Oct 19, 2023	BUY	$369.35 - $548.43 $503,793 - $748,058	1,364 Added 5.23%	27,466 $13.5 Million
Q2 2023 Aug 02, 2023	BUY	$360.14 - $422.58 $2.48 Million - $2.91 Million	6,894 Added 35.89%	26,102 $10.2 Million
Q1 2023 Apr 28, 2023	SELL	$334.23 - $403.65 $256,354 - $309,599	-767 Reduced 3.84%	19,208 $7.16 Million
Q4 2022 Feb 07, 2023	BUY	$342.17 - $402.31 $6.83 Million - $8.04 Million	19,975 New	19,975 $7.57 Million
Q2 2022 Aug 03, 2022	SELL	$269.58 - $378.88 $2.02 Million - $2.84 Million	-7,500 Closed	0 $0
Q1 2022 May 11, 2022	BUY	$254.45 - $351.06 $101,780 - $140,424	400 Added 5.63%	7,500 $2.37 Million
Q4 2021 Feb 08, 2022	SELL	$272.01 - $353.03 $380,814 - $494,241	-1,400 Reduced 16.47%	7,100 $2.49 Million
Q2 2021 Aug 03, 2021	SELL	$257.11 - $319.92 $102,844 - $127,968	-400 Reduced 4.49%	8,500 $2.56 Million
Q1 2021 Apr 29, 2021	SELL	$268.3 - $380.31 $268,300 - $380,310	-1,000 Reduced 10.1%	8,900 $2.45 Million
Q4 2020 Feb 11, 2021	BUY	$248.13 - $308.36 $24,813 - $30,836	100 Added 1.02%	9,900 $2.91 Million
Q3 2020 Nov 13, 2020	BUY	$215.51 - $272.51 $387,918 - $490,518	1,800 Added 22.5%	9,800 $2.57 Million
Q2 2020 Aug 13, 2020	BUY	$127.44 - $232.72 $1.02 Million - $1.86 Million	8,000 New	8,000 $1.8 Million

Others Institutions Holding ARGX

# of Institutions

400

Shares Held

30.9M

Call Options Held

376K

Put Options Held

489K

View Full List

About ARGENX SE

Ticker ARGX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 55,323,800
Market Cap $31.2B
Description
argenx SE, a biotechnology company, focuses on developing various therapies for the treatment of autoimmune diseases in the United States, the Netherlands, Belgium, Japan, Switzerland, Germany and France. Its lead product candidate is efgartigimod for the treatment of patients with myasthenia gravis, immune thrombocytopenia, pemphigus vulgaris, ...

More about ARGX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Handelsbanken Fonder Ab, based on Form 13F filings with the SEC.

News

Stay updated on Handelsbanken Fonder Ab with notifications on news.

Account

Handelsbanken Fonder Ab Argenx Se Transaction History